JMI LABS IS NOW PART OF LEARN MORE

Antimicrobial activty of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes. by Sader HS, Rhomberg PR, Farrell DJ, Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (5): 2390-2394

View on Pubmed